Methods of using ajoene
US5948821A · kind A · utility
3Cited by
9References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 1996 |
| Grant date | Sep 7, 1999 |
| Priority date | — |
| Expiry date | Jan 11, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/39
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The progression of infection and other pathologies produced by a viral infection may be inhibited by administering an effective dosage of Ajoene. Additionally, Ajoene has anti-tumor, anti-shock, and antiinflammation effects. In general, Ajoene may be used to treat any integrin-mediated disease or condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.